Literature DB >> 21537856

Peritoneal dialysis in an ageing population: a 10-year experience.

Andrew Smyth1, Evonne McCann, Lynn Redahan, Barbara Lambert, George J Mellotte, Catherine A Wall.   

Abstract

BACKGROUND: Chronic kidney disease (CKD) is becoming increasingly prevalent and there are increasing numbers of older patients with advanced CKD. Peritoneal dialysis (PD) is a potential treatment. This study aims to compare PD outcomes in age-defined populations in the largest PD centre in the Republic of Ireland over 10 years.
METHODS: We retrospectively identified all adult patients, over the age of 50 years, who commenced PD as their first modality of renal replacement therapy (RRT) between 1 January 1998 and 31 December 2008 at our institution. Primary outcome was patient survival; secondary outcomes were technique failure, peritonitis-free survival, transplantation and hospitalisations.
RESULTS: One hundred and forty-eight patients with a mean age of 63 years were included. Twenty-two patients were on assisted PD, the majority of whom were aged 70 years or over (P = 0.001). There were no differences in patient survival or technique failure by age group, Charlson Co-Morbidity Index (CCI), modified-CCI or adjusted CCI. Renal transplantation occurred predominantly in younger patients (P = 0.001) with lower m-CCI (P = 0.001) and a-CCI (P = 0.002) who performed PD independently (P = 0.004). Older patients required longer hospital stays to initiate PD (P = 0.004). Assisted PD was not associated with an increase in early complications or technique failure but death rates were higher (P = 0.002).
CONCLUSION: This study shows PD to be an acceptable modality of renal replacement therapy in elderly patients, with no observed differences in survival, technique survival or complication rates. Co-morbidities appear to play a stronger role in predicting survival than age alone. Assisted PD is a viable option in those unable to undergo PD independently.

Entities:  

Mesh:

Year:  2011        PMID: 21537856     DOI: 10.1007/s11255-011-9973-2

Source DB:  PubMed          Journal:  Int Urol Nephrol        ISSN: 0301-1623            Impact factor:   2.370


  24 in total

1.  Educating end-stage renal disease patients on dialysis modality selection: clinical advice from the European Renal Best Practice (ERBP) Advisory Board.

Authors:  Adrian Covic; Bert Bammens; Thierry Lobbedez; Liviu Segall; Olof Heimbürger; Wim van Biesen; Denis Fouque; Raymond Vanholder
Journal:  Nephrol Dial Transplant       Date:  2010-04-14       Impact factor: 5.992

2.  A clinical score to predict 6-month prognosis in elderly patients starting dialysis for end-stage renal disease.

Authors:  Cécile Couchoud; Michel Labeeuw; Olivier Moranne; Vincent Allot; Vincent Esnault; Luc Frimat; Bénédicte Stengel
Journal:  Nephrol Dial Transplant       Date:  2008-12-18       Impact factor: 5.992

3.  Prediction of early death in end-stage renal disease patients starting dialysis.

Authors:  B J Barrett; P S Parfrey; J Morgan; P Barré; A Fine; M B Goldstein; S P Handa; K K Jindal; C M Kjellstrand; A Levin; H Mandin; N Muirhead; R M Richardson
Journal:  Am J Kidney Dis       Date:  1997-02       Impact factor: 8.860

4.  A simple comorbidity scale predicts clinical outcomes and costs in dialysis patients.

Authors:  S Beddhu; F J Bruns; M Saul; P Seddon; M L Zeidel
Journal:  Am J Med       Date:  2000-06-01       Impact factor: 4.965

5.  Peritoneal dialysis in elderly patients: report from the French Peritoneal Dialysis Registry (RDPLF).

Authors:  Cindy Castrale; David Evans; Christian Verger; Emmanuel Fabre; Didier Aguilera; Jean-Philippe Ryckelynck; Thierry Lobbedez
Journal:  Nephrol Dial Transplant       Date:  2009-08-07       Impact factor: 5.992

6.  213 elderly uremic patients over 75 years of age treated with long-term peritoneal dialysis: a French multicenter study.

Authors:  B Issad; D Benevent; M Allouache; P Y Durand; D Aguilera; R Milongo; P Dubot; S Lavaud; J Gary
Journal:  Perit Dial Int       Date:  1996       Impact factor: 1.756

7.  Prognostic survival factors in elderly renal failure patients treated with peritoneal dialysis: a nine-year retrospective study.

Authors:  Sandrine Genestier; Nicolas Meyer; François Chantrel; Farideh Alenabi; Pierre Brignon; Mehadji Maaz; Sandrine Muller; Bernadette Faller
Journal:  Perit Dial Int       Date:  2010-02-01       Impact factor: 1.756

8.  The effect of contraindications and patient preference on dialysis modality selection in ESRD patients in The Netherlands.

Authors:  Kitty J Jager; Johanna C Korevaar; Friedo W Dekker; Raymond T Krediet; Elisabeth W Boeschoten
Journal:  Am J Kidney Dis       Date:  2004-05       Impact factor: 8.860

9.  Effect of end-stage renal disease on the quality of life of older patients.

Authors:  Carole Loos; Serge Briançon; Luc Frimat; Bernadette Hanesse; Michèle Kessler
Journal:  J Am Geriatr Soc       Date:  2003-02       Impact factor: 5.562

10.  Good patient and technique survival in elderly patients on continuous ambulatory peritoneal dialysis.

Authors:  Philip Kam-Tao Li; Man Ching Law; Kai Ming Chow; Chi-Bon Leung; Bonnie Ching-Ha Kwan; Kwok Yi Chung; Cheuk-Chun Szeto
Journal:  Perit Dial Int       Date:  2007-06       Impact factor: 1.756

View more
  10 in total

1.  Prevalence of CMMSE defined cognitive impairment among peritoneal dialysis patients and its impact on peritonitis.

Authors:  Yat Fung Shea; Man-Fai Lam; Mi Suen Connie Lee; Ming Yee Maggie Mok; Sing-Leung Lui; Terence P S Yip; Wai Kei Lo; Leung Wing Chu; Tak-Mao Chan
Journal:  Clin Exp Nephrol       Date:  2015-05-21       Impact factor: 2.801

2.  Hospitalization Rates for Patients on Assisted Peritoneal Dialysis Compared with In-Center Hemodialysis.

Authors:  Matthew J Oliver; Ahmed A Al-Jaishi; Stephanie N Dixon; Jeffrey Perl; Arsh K Jain; Susan D Lavoie; Danielle M Nash; J Michael Paterson; Charmaine E Lok; Robert R Quinn
Journal:  Clin J Am Soc Nephrol       Date:  2016-07-27       Impact factor: 8.237

3.  Prevalence of Cognitive Impairment Among Peritoneal Dialysis Patients, Impact on Peritonitis and Role of Assisted Dialysis.

Authors:  Yat Fung Shea; Man Fai Lam; Mi Suen Connie Lee; Ming Yee Maggie Mok; Sing-Leung Lui; Terence P S Yip; Wai Kei Lo; Leung Wing Chu; Tak-Mao Chan
Journal:  Perit Dial Int       Date:  2015-12-03       Impact factor: 1.756

4.  Elderly Peritoneal Dialysis Compared with Elderly Hemodialysis Patients and Younger Peritoneal Dialysis Patients: Competing Risk Analysis of a Korean Prospective Cohort Study.

Authors:  Hyunsuk Kim; Jung Nam An; Dong Ki Kim; Myoung-Hee Kim; Ho Kim; Yong-Lim Kim; Ki Soo Park; Yun Kyu Oh; Chun Soo Lim; Yon Su Kim; Jung Pyo Lee
Journal:  PLoS One       Date:  2015-06-29       Impact factor: 3.240

5.  Outcomes of peritoneal dialysis in elderly vs non-elderly patients: A systemic review and meta-analysis.

Authors:  Chunling Jiang; Qiang Zheng
Journal:  PLoS One       Date:  2022-02-08       Impact factor: 3.240

6.  High intraperitoneal interleukin-6 levels predict ultrafiltration (UF) insufficiency in peritoneal dialysis patients: A prospective cohort study.

Authors:  Qianhui Song; Xiaoxiao Yang; Yuanyuan Shi; Hao Yan; Zanzhe Yu; Zhenyuan Li; Jiangzi Yuan; Zhaohui Ni; Leyi Gu; Wei Fang
Journal:  Front Med (Lausanne)       Date:  2022-08-10

7.  Assisted peritoneal dialysis: a feasible KRT modality for frail older patients with end-stage kidney disease (ESKD).

Authors:  Qianhui Song; Hao Yan; Zanzhe Yu; Zhenyuan Li; Jiangzi Yuan; Zhaohui Ni; Wei Fang
Journal:  Sci Rep       Date:  2021-07-22       Impact factor: 4.379

8.  End-Stage Renal Disease and Renal Replacement Therapy in older Patients.

Authors:  Andrew Smyth
Journal:  Nephrourol Mon       Date:  2012-03-01

Review 9.  Chronic kidney disease and support provided by home care services: a systematic review.

Authors:  Sema K Aydede; Paul Komenda; Ognjenka Djurdjev; Adeera Levin
Journal:  BMC Nephrol       Date:  2014-07-18       Impact factor: 2.388

Review 10.  Overcoming the Underutilisation of Peritoneal Dialysis.

Authors:  Jernej Pajek
Journal:  Biomed Res Int       Date:  2015-11-11       Impact factor: 3.411

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.